TERN — Terns Pharmaceuticals Share News
0.000.00%
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.
Brief: Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks
U.S. RESEARCH ROUNDUP- Equitable Holdings, Robinhood Markets, Wingstop
U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings
U.S. STOCKS ON THE MOVE-BWX, Generac, Cintas
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Arm, On Holding, Sarepta
Enliven gains after Jones raises PT on increased takeover appeal
U.S. STOCKS ON THE MOVE-Arm, Destiny Tech100, Terns Pharma
Terns Pharma climbs on Merck's $6.7 bln takeover deal
Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma (updated)
Merck boosts cancer portfolio with $6.7 billion buyout of Terns Pharma
Terns Pharma jumps after report Merck nears $6 bln takeover
Deals of the day-Mergers and acquisitions
Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports (updated)